Re: UK should be grateful
Originally Posted by
AnnieS
->
I don't understand your post or the fuss about this.
Britain's supply of AZ is manufactured in India. We have also ordered 17m doses of Moderna. Probably with more to follow. The AZ remaining stocks are being used for second vaccines with Moderna being used for new vaccines of younger cohorts. Considering people are turning down AZ because of all the bad publicity I can't see us running short.
I'm still trying to work out how our supply is so affected by the EU. Moderna is manufactured in the US. We have already received about 50m doses of AZ. Most of our AZ is manufactured in the UK. This is a dispute between the EU and AZ and not between the EU and the UK.
The UK is definitely ahead of the curve on this.
Ouch! Haven't you heard AZ is sueing india becayse they blocked the vaccines produced there?
https://www.bbc.com/news/world-asia-india-56659206
The EU’s*vaccine*tsar has said that*AstraZeneca*has agreed that all but one batch of its Covid vaccine produced at a Netherlands plant will be sent to European member states rather than Britain.
In an interview on Friday,*Thierry Breton*said that “zero” doses made in the EU would be sanctioned for delivery to the UK until AstraZeneca fulfilled its contract with the bloc.
There was no immediate response from the Anglo-Swedish pharmaceuticals giant to Mr Breton’s assertion that the company had acknowledged that all but 1.2-1.5 million doses of vaccine produced at the Halix plant in Leiden, the Netherlands, as well as the plant in Seneffe, Belgium, were for the EU.
Mr Breton said: “I organised a video teleconference between the CEO of Halix and the CEO of AstraZeneca, and finally the CEO of AstraZeneca recognised that all the production of Halix was planned to support the EU delivery. That is all I can tell you.
The CEO of AstraZeneca told us that in fact since February all the production of Halix has been planned to be delivered to Europe except, he said, one batch, to be very precise.”
The British policy of prioritising first doses was completely understandable, but it means it now has to find second doses, and in a hurry,” he said. “I don’t want to make anyone anxious, we will of course do all we can to meet their needs, but we also have certain constraints in Europe.”
While the first phase of the UK’s vaccination rollout was “hugely impressive”, he said Britain was “starting to realise that one dose is not enough, that you also need second doses – and that, to a large extent, it will be dependent on Europe.”*